BCMIO
GSK icon

Beacon Capital Management Inc (Ohio)’s GSK GSK Stock Holding History

Beacon Capital Management Inc (Ohio)’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1
Closed – – 124
2017
Q1 		$0 Buy
+1
New +$51 ﹤0.01% 130

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Beacon Capital Management Inc (Ohio)'s GSK Position: Q2 2017 in Review

Beacon Capital Management Inc (Ohio) sold out of GSK (GSK) in Q2 2017, closing a stake of 1 share.

Beacon Capital Management Inc (Ohio) first reported a position in GSK in Q1 2017 and held it in 1 quarter. The position peaked at $0 in Q1 2017. 779 funds tracked by Wall St. Rank hold GSK as of Q2 2017.

  • Beacon Capital Management Inc (Ohio) reported no remaining GSK position as of Q2 2017 after selling out during the quarter.
  • Beacon Capital Management Inc (Ohio) sold 1 GSK share in Q2 2017.
  • Beacon Capital Management Inc (Ohio) first reported a position in GSK in Q1 2017 and held it in 1 quarter.
  • Beacon Capital Management Inc (Ohio)'s GSK position peaked at $0 in Q1 2017.
  • 779 funds tracked by Wall St. Rank held GSK as of Q2 2017.

Based on Beacon Capital Management Inc (Ohio)'s 13F filing for Q2 2017, filed 11 Jul 2017.